Literature DB >> 12435411

NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells.

R Ientile1, D Caccamo, V Macaione, V Torre, S Macaione.   

Abstract

In neuronal cells, excessive activation of glutamate receptors causes excitotoxic damage culminating in apoptotic and necrotic cell death. The molecular mechanism of excitotoxicity has been associated with excessive Ca(2+) influx and overload, triggering biochemical events that lead to cell death and tissue degeneration. Following mild insults via NMDA-receptor activation, central neurons undergo several biochemical modifications recognizable as early events in apoptotic machinery.Tissue transglutaminase, the most ubiquitous among cell transglutaminases, catalyzes the Ca(2+)-dependent protein cross-linking probably associated with morphological changes in several neurodegenerative disorders. The possible involvement of this enzyme in excitotoxicity-mediated events was investigated in primary cultures of cerebellar granule cells exposed for 30 min to NMDA (100 microM) in Locke's buffer. Under these conditions time-dependent increases in transglutaminase activity were observed. Tissue transglutaminase expression reached the highest levels within 3-4 h of NMDA exposure. Similarly, high levels of incorporation of fluorescent substrates were observed in living cells. Confocal laser microscopy analysis showed that fluorescein-labelled structures were distributed within the cytoplasm and close to the membranes of NMDA-exposed cells. These effects were dependent on the Ca(2+) influx triggered by the excitotoxic stimulus. Morphological changes in NMDA-treated cells gave evidence of significant cell damage which appeared within 5-6 h of NMDA exposure. These results suggest that increases in tissue transglutaminase may be associated to the effects of NMDA-induced excitotoxicity. Therefore, it is reasonable to hypothesize that if tissue transglutaminase levels and activity are up-regulated under such conditions, the protein cross-linking could be likely involved in excitotoxic response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435411     DOI: 10.1016/s0306-4522(02)00482-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Effect of acetylcholine precursors on proliferation and differentiation of astroglial cells in primary cultures.

Authors:  V Bramanti; A Campisi; D Tomassoni; G Li Volti; D Caccamo; G Cannavò; M Currò; G Raciti; M Napoli; R Ientile; A Vanella; F Amenta; Roberto Avola
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

Review 2.  Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block.

Authors:  Manuela Basso; Rajiv R Ratan
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-10       Impact factor: 6.200

Review 3.  Physiological, pathological, and structural implications of non-enzymatic protein-protein interactions of the multifunctional human transglutaminase 2.

Authors:  Kajal Kanchan; Mónika Fuxreiter; László Fésüs
Journal:  Cell Mol Life Sci       Date:  2015-05-06       Impact factor: 9.261

4.  Comparative Examination of Temporal Glyoxalase 1 Variations Following Perforant Pathway Transection, Excitotoxicity, and Controlled Cortical Impact Injury.

Authors:  Philipp Pieroh; Daniel-Christoph Wagner; Beat Alessandri; Mojgan Dabbagh Nazari; Angela Ehrlich; Chalid Ghadban; Constance Hobusch; Gerd Birkenmeier; Faramarz Dehghani
Journal:  Neurotox Res       Date:  2017-09-12       Impact factor: 3.911

5.  Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.

Authors:  Anthony J Filiano; Craig D C Bailey; Janusz Tucholski; Soner Gundemir; Gail V W Johnson
Journal:  FASEB J       Date:  2008-03-28       Impact factor: 5.191

Review 6.  Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.

Authors:  Benjamin R Underwood; David C Rubinsztein
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

7.  Temporal dynamics of glyoxalase 1 in secondary neuronal injury.

Authors:  Philipp Pieroh; Marco Koch; Daniel-Christoph Wagner; Johannes Boltze; Angela Ehrlich; Chalid Ghadban; Constance Hobusch; Gerd Birkenmeier; Faramarz Dehghani
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.